Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CStone Pharmaceuticals Director's Dealing 2022

Jul 19, 2022

50715_rns_2022-07-19_c2f60fb1-1da1-4ce3-bbc3-567fe22c6309.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

==> picture [173 x 58] intentionally omitted <==

Public Disclosure Form

19 July 2022

Possible offer

Disclosure of dealings in the shares of Yankuang Energy Group Company Limited

The Executive received the following disclosure of securities dealings pursuant to Rule 22 of the Hong Kong Code on Takeovers and Mergers:

Party Date Description
of relevant
securities
Description
of products
Nature of
dealings
Number of
reference
securities to
which the
derivatives
relate
Maturity
date /
closing out
date
Reference
price
Total amount
paid / received
Resultant
balance
(including
those of any
person with
whom there is
an agreement
or
understanding)
CICC Pucheng
Investment Co.,
Ltd.
18 July 2022 Derivatives Other types
of products
Closing out of a
derivative contract
2,000 18 July 2022 $24.1000 $48,200.0000 0
Derivatives Other types
of products
Closing out of a
derivative contract
2,000 20 July 2023 $24.0547 $48,109.4600 936,000

End

==> picture [71 x 43] intentionally omitted <==

Public Disclosure Form

Note:

CICC Pucheng Investment Co., Ltd. is an exempt principal trader connected with the Offeror.

Dealings were made for its own account.

CICC Pucheng Investment Co., Ltd. is ultimately owned by China International Capital Corporation Limited.